USANA (USNA) director Ding Xia logs RSU vesting and share sale in Form 4

Rhea-AI Filing Summary

USANA Health Sciences director Ding Xia reported stock transactions related to vesting equity awards. On January 22, 2026, 1,058 restricted stock units converted into the same number of USANA common shares at an exercise price of $0.00. These shares came from previously granted equity that vests in four 25% installments on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

On the same day, 392 common shares were disposed of at $22.51 per share in a transaction coded "F," which typically reflects shares withheld to cover taxes on the vesting. After these transactions, Ding Xia directly held 6,584 shares of USANA common stock and 1,057 restricted stock units as derivative securities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ding Xia

(Last) (First) (Middle)

3838 WEST PARKWAY BLVD.

(Street)

SALT LAKE CITY UT 84120

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/22/2026		M		1,058	A	(1)	6,976	D
Common Stock	01/22/2026		F		392	D	$22.51	6,584	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/22/2026		M			1,058	(2)	(2)	Common Stock	1,058	$0	1,057	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	01/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider in this USANA (USNA) Form 4 filing?

The filing reports transactions by Ding Xia, who is listed as a director of USANA Health Sciences, Inc.

What equity awards vested for USANA (USNA) director Ding Xia on January 22, 2026?

On January 22, 2026, 1,058 restricted stock units vested and were converted into an equal number of USANA common shares at an exercise price of $0.00.

Why were 392 USANA (USNA) shares disposed of in the Form 4?

The Form 4 shows a transaction coded "F" for 392 common shares at $22.51 per share, which typically indicates shares withheld or sold to satisfy tax obligations related to the vesting of restricted stock units.

How many USANA (USNA) shares does Ding Xia own after these transactions?

After the reported transactions, Ding Xia directly owned 6,584 shares of USANA common stock.

How many restricted stock units does Ding Xia hold after the January 22, 2026 vesting?

Following the vesting and conversion of 1,058 restricted stock units, 1,057 restricted stock units remained beneficially owned as derivative securities.

What is the vesting schedule for Ding Xias USANA (USNA) restricted stock units?

The restricted stock units vest 25% on each of these dates: July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.